Anebulo Pharmaceuticals Stock Market Value
| ANEB Stock | USD 0.48 0.01 2.13% |
| Symbol | Anebulo |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anebulo Pharmaceuticals. If investors know Anebulo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Anebulo Pharmaceuticals assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Investors evaluate Anebulo Pharmaceuticals using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Anebulo Pharmaceuticals' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause Anebulo Pharmaceuticals' market price to deviate significantly from intrinsic value.
Understanding that Anebulo Pharmaceuticals' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Anebulo Pharmaceuticals represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Anebulo Pharmaceuticals' market price signifies the transaction level at which participants voluntarily complete trades.
Anebulo Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Anebulo Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Anebulo Pharmaceuticals.
| 11/15/2025 |
| 02/13/2026 |
If you would invest 0.00 in Anebulo Pharmaceuticals on November 15, 2025 and sell it all today you would earn a total of 0.00 from holding Anebulo Pharmaceuticals or generate 0.0% return on investment in Anebulo Pharmaceuticals over 90 days. Anebulo Pharmaceuticals is related to or competes with Tiziana Life, Immix Biopharma, Whitehawk Therapeutics, Zentalis Pharmaceuticals, Coya Therapeutics, Pliant Therapeutics, and Clene. Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatme... More
Anebulo Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Anebulo Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Anebulo Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.25) | |||
| Maximum Drawdown | 58.34 | |||
| Value At Risk | (15.74) | |||
| Potential Upside | 5.06 |
Anebulo Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Anebulo Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Anebulo Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Anebulo Pharmaceuticals historical prices to predict the future Anebulo Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.19) | |||
| Jensen Alpha | (1.89) | |||
| Total Risk Alpha | (2.61) | |||
| Treynor Ratio | 1.06 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Anebulo Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Anebulo Pharmaceuticals February 13, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.19) | |||
| Market Risk Adjusted Performance | 1.07 | |||
| Mean Deviation | 4.92 | |||
| Coefficient Of Variation | (408.92) | |||
| Standard Deviation | 8.16 | |||
| Variance | 66.62 | |||
| Information Ratio | (0.25) | |||
| Jensen Alpha | (1.89) | |||
| Total Risk Alpha | (2.61) | |||
| Treynor Ratio | 1.06 | |||
| Maximum Drawdown | 58.34 | |||
| Value At Risk | (15.74) | |||
| Potential Upside | 5.06 | |||
| Skewness | (2.10) | |||
| Kurtosis | 8.34 |
Anebulo Pharmaceuticals Backtested Returns
Anebulo Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.25, which signifies that the company had a -0.25 % return per unit of standard deviation over the last 3 months. Anebulo Pharmaceuticals exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Anebulo Pharmaceuticals' risk adjusted performance of (0.19), and Mean Deviation of 4.92 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of -1.89, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Anebulo Pharmaceuticals are expected to decrease by larger amounts. On the other hand, during market turmoil, Anebulo Pharmaceuticals is expected to outperform it. At this point, Anebulo Pharmaceuticals has a negative expected return of -2.1%. Please make sure to confirm Anebulo Pharmaceuticals' jensen alpha, skewness, and the relationship between the variance and treynor ratio , to decide if Anebulo Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.91 |
Excellent predictability
Anebulo Pharmaceuticals has excellent predictability. Overlapping area represents the amount of predictability between Anebulo Pharmaceuticals time series from 15th of November 2025 to 30th of December 2025 and 30th of December 2025 to 13th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Anebulo Pharmaceuticals price movement. The serial correlation of 0.91 indicates that approximately 91.0% of current Anebulo Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.91 | |
| Spearman Rank Test | 0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Anebulo Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Anebulo Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Anebulo Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Anebulo Pharmaceuticals Stock:Check out Anebulo Pharmaceuticals Correlation, Anebulo Pharmaceuticals Volatility and Anebulo Pharmaceuticals Performance module to complement your research on Anebulo Pharmaceuticals. For information on how to trade Anebulo Stock refer to our How to Trade Anebulo Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Anebulo Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.